Development of Transplantation Vasculopathy and Progression of Donor-Transmitted Atherosclerosis

Abstract

Background-Transplant coronary artery disease is a combination of atherosclerosis transmitted from the donor and new lesions of allograft vasculopathy. We sought to determine the morphological characteristics of allograft vasculopathy and differentiate it from donor-transmitted atherosclerosis with serial intravascular ultrasound. Methods and Results-Intravascular ultrasound examination was performed in 93 patients at 27.2Ϯ15.0 and 369.7Ϯ23.9 days after transplantation. The maximally and minimally diseased sites were selected in each segment as defined by Coronary Artery Surgery Study classification. For each matched site, maximal plaque thickness was measured. Lesions (maximum plaque thickness Ն0.5 mm) present at baseline examination were defined as donor lesions. On follow-up, lesions that developed at previously normal sites were defined as de novo lesions. The distribution and severity of donor and de novo lesions were similar in proximal, mid, and distal segments. The de novo lesions were less focal (43% vs 74%) and more circumferential (69% vs 45%) compared with the donor lesions, but there was significant morphological heterogeneity. Similar numbers of patients with and those without donor lesions developed de novo lesions. Moreover, progression of donor lesions was not associated with the presence or absence of de novo lesions. Conclusions-Differentiation between early allograft vasculopathy from conventional atherosclerosis by distribution and morphology of lesions alone is difficult. Serial intravascular ultrasound imaging with early baseline examination is necessary to make this distinction. This distinction is important because the progression of donor lesions and the development of de novo lesions are independent of each other. (Circulation. 1998;98:2672-2678.)

Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor–Deficient Mice

“…Whether measurement of autoantibody titers to OxLDL will be useful in assessing the regression of human atherosclerotic lesions needs to be evaluated in studies using quantitative techniques (such as intracoronary ultrasound) that completely assess the atherosclerotic plaque burden. 40 …”

Intravascular Ultrasound-Derived Virtual Fractional Flow Reserve for the Assessment of Myocardial Ischemia

“…An IVUS lesion was defined as >0.5-mm atherosclerotic plaque thickness. 16 Gray-scale IVUS and ultrasound signals were acquired with a commercially available IVUS imaging system (VISIWAVE, Terumo) using a 43-MHz mechanically rotating IVUS catheter (View IT, Terumo). IVUS was performed using motorized pullback at 0.5 mm/s to include proximal and distal Luer connectors.…”

Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study

“…The speed of CAV progression and the time of occurrence after transplantation are therefore the main risk factors for undesirable results after HTx (ref. 12 ). It must be remembered, however, that the anatomic condition of CAV must be understood only as part of a syndrome in which the presence or absence of graft dysfunction as a result of CAV plays the key role and this dysfunction represents another strong predictive factor of impaired prognosis.…”